FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2333519782> ?p ?o ?g. }

• W2333519782 endingPage "2262" @default.
• W2333519782 startingPage "2252" @default.
• W2333519782 abstract "Based on randomized trials using first-generation devices, transcatheter aortic valve replacement (TAVR) is well established in the treatment of high-risk (HR) patients with severe aortic stenosis (AS). To date, there is a paucity of adjudicated, prospective data evaluating outcomes with newer generation devices and in lower risk patients. We report early outcomes of a large, multicentre registry of inoperable, HR, and intermediate-risk (IR) patients undergoing treatment with the next-generation SAPIEN 3 transcatheter heart valve (THV).Patients with severe, symptomatic AS (583 high surgical risk or inoperable and 1078 IR) were enrolled in a multicentre, non-randomized registry at 57 sites in the USA and Canada. All patients received TAVR with the SAPIEN 3 system via transfemoral (n = 1443, 86.9%) and transapical or transaortic (n = 218, 13.1%) access routes. The rate of 30-day all-cause mortality was 2.2% in HR/inoperable patients [mean Society of Thoracic Surgeons (STS) score 8.7%] and 1.1% in IR patients (mean STS score 5.3%); cardiovascular mortality was 1.4 and 0.9%, respectively. In HR/inoperable patients, the 30-day rate of major/disabling stroke was 0.9%, major bleeding 14.0%, major vascular complications 5.1%, and requirement for permanent pacemaker 13.3%. In IR patients, the 30-day rate of major/disabling stroke was 1.0%, major bleeding 10.6%, major vascular complications 6.1%, and requirement for permanent pacemaker 10.1%. Mean overall Kansas City Cardiomyopathy Questionnaire score increased from 47.8 to 67.8 (HR/inoperable, P < 0.0001) and 54.7 to 74.0 (IR, P < 0.0001). Overall, paravalvular regurgitation at 30 days was none/trace in 55.9% of patients, mild in 40.7%, moderate in 3.4%, and severe in 0.0%. Mean gradients among patients with paired baseline and 30-day or discharge echocardiograms decreased from 45.8 mmHg at baseline to 11.4 mmHg at 30 days, while aortic valve area increased from 0.69 to 1.67 cm(2).The SAPIEN 3 THV system was associated with low rates of 30-day mortality and major/disabling stroke as well as low rates of moderate or severe paravalvular regurgitation.ClinicalTrials.gov #NCT01314313." @default.
• W2333519782 created "2016-06-24" @default.
• W2333519782 creator A5000568658 @default.
• W2333519782 creator A5000585463 @default.
• W2333519782 creator A5007473059 @default.
• W2333519782 creator A5007558252 @default.
• W2333519782 creator A5009728510 @default.
• W2333519782 creator A5013753855 @default.
• W2333519782 creator A5019062163 @default.
• W2333519782 creator A5019475815 @default.
• W2333519782 creator A5021275081 @default.
• W2333519782 creator A5029718548 @default.
• W2333519782 creator A5040339119 @default.
• W2333519782 creator A5041084808 @default.
• W2333519782 creator A5041560526 @default.
• W2333519782 creator A5052055726 @default.
• W2333519782 creator A5054472046 @default.
• W2333519782 creator A5055613208 @default.
• W2333519782 creator A5056375893 @default.
• W2333519782 creator A5056991193 @default.
• W2333519782 creator A5069528979 @default.
• W2333519782 creator A5070739244 @default.
• W2333519782 creator A5074361601 @default.
• W2333519782 creator A5079749832 @default.
• W2333519782 creator A5082003758 @default.
• W2333519782 creator A5082587372 @default.
• W2333519782 creator A5082924210 @default.
• W2333519782 creator A5084185852 @default.
• W2333519782 creator A5086890034 @default.
• W2333519782 creator A5086970664 @default.
• W2333519782 date "2016-03-31" @default.
• W2333519782 modified "2023-10-13" @default.
• W2333519782 title "Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis" @default.
• W2333519782 cites W105422400 @default.
• W2333519782 cites W1158639029 @default.
• W2333519782 cites W132511837 @default.
• W2333519782 cites W1424622492 @default.
• W2333519782 cites W1894479445 @default.
• W2333519782 cites W1938921375 @default.
• W2333519782 cites W2003993796 @default.
• W2333519782 cites W2037507673 @default.
• W2333519782 cites W2041617439 @default.
• W2333519782 cites W2052593408 @default.
• W2333519782 cites W2058377958 @default.
• W2333519782 cites W2067905792 @default.
• W2333519782 cites W2081463532 @default.
• W2333519782 cites W2091671279 @default.
• W2333519782 cites W2109553540 @default.
• W2333519782 cites W2127630635 @default.
• W2333519782 cites W2131958422 @default.
• W2333519782 cites W2132585880 @default.
• W2333519782 cites W2149609916 @default.
• W2333519782 cites W2165258820 @default.
• W2333519782 cites W2217533272 @default.
• W2333519782 cites W2227679270 @default.
• W2333519782 cites W2605849388 @default.
• W2333519782 cites W2698758261 @default.
• W2333519782 cites W432037510 @default.
• W2333519782 doi "https://doi.org/10.1093/eurheartj/ehw112" @default.
• W2333519782 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6392433" @default.
• W2333519782 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27190101" @default.
• W2333519782 hasPublicationYear "2016" @default.
• W2333519782 type Work @default.
• W2333519782 sameAs 2333519782 @default.
• W2333519782 citedByCount "291" @default.
• W2333519782 countsByYear W23335197822016 @default.
• W2333519782 countsByYear W23335197822017 @default.
• W2333519782 countsByYear W23335197822018 @default.
• W2333519782 countsByYear W23335197822019 @default.
• W2333519782 countsByYear W23335197822020 @default.
• W2333519782 countsByYear W23335197822021 @default.
• W2333519782 countsByYear W23335197822022 @default.
• W2333519782 countsByYear W23335197822023 @default.
• W2333519782 crossrefType "journal-article" @default.
• W2333519782 hasAuthorship W2333519782A5000568658 @default.
• W2333519782 hasAuthorship W2333519782A5000585463 @default.
• W2333519782 hasAuthorship W2333519782A5007473059 @default.
• W2333519782 hasAuthorship W2333519782A5007558252 @default.
• W2333519782 hasAuthorship W2333519782A5009728510 @default.
• W2333519782 hasAuthorship W2333519782A5013753855 @default.
• W2333519782 hasAuthorship W2333519782A5019062163 @default.
• W2333519782 hasAuthorship W2333519782A5019475815 @default.
• W2333519782 hasAuthorship W2333519782A5021275081 @default.
• W2333519782 hasAuthorship W2333519782A5029718548 @default.
• W2333519782 hasAuthorship W2333519782A5040339119 @default.
• W2333519782 hasAuthorship W2333519782A5041084808 @default.
• W2333519782 hasAuthorship W2333519782A5041560526 @default.
• W2333519782 hasAuthorship W2333519782A5052055726 @default.
• W2333519782 hasAuthorship W2333519782A5054472046 @default.
• W2333519782 hasAuthorship W2333519782A5055613208 @default.
• W2333519782 hasAuthorship W2333519782A5056375893 @default.
• W2333519782 hasAuthorship W2333519782A5056991193 @default.
• W2333519782 hasAuthorship W2333519782A5069528979 @default.
• W2333519782 hasAuthorship W2333519782A5070739244 @default.
• W2333519782 hasAuthorship W2333519782A5074361601 @default.
• W2333519782 hasAuthorship W2333519782A5079749832 @default.
• W2333519782 hasAuthorship W2333519782A5082003758 @default.
• W2333519782 hasAuthorship W2333519782A5082587372 @default.

• next